Herrera, Maria Beatriz; Department of Internal Medicine, Molecular Biotechnology Center, University of Turin, Italy ; Sis-Ter S.p.A., Palazzo Pignano (CR), Italy
Fonsato, Valentina; Department of Internal Medicine, Molecular Biotechnology Center, University of Turin, Italy
Bruno, Stefania; Department of Internal Medicine, Molecular Biotechnology Center, University of Turin, Italy
Grange, Cristina; Department of Internal Medicine, Molecular Biotechnology Center, University of Turin, Italy
Gilbo, NICHOLAS ; Université de Liège - ULiège > Département des sciences cliniques > Pathologie chirurgicale abdominale et endocrinienne ; Centre Hospitalier Universitaire de Liège - CHU > > Service de chirurgie abdo, sénologique, endocrine et de transplantation
Romagnoli, Renato; Liver Transplantation Center, University of Torino, Torino, Italy
Tetta, Ciro; Fresenius Medical Care, Bad Homburg, Germany
Camussi, Giovanni; Department of Internal Medicine, Molecular Biotechnology Center, University of Turin, Italy
Language :
English
Title :
Human liver stem cells improve liver injury in a model of fulminant liver failure
Russo FP, Parola M. Stem and progenitor cells in liver regeneration and repair. Cytotherapy. 2011; 13: 135-144.
Kobayashi N, Okitsu T, Tanaka N. Cell choice for bioartificial livers. Keio J Med 2003; 52: 151-157.
Oertel M, Shafritz DA. Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta 2008; 1782: 61-74.
Stock P, Brückner S, Ebensing S, Hempel M, Dollinger MM, Christ B. The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver. Nat Protoc 2010; 5: 617-627.
Piryaei A, Valojerdi MR, Shahsavani M, Baharvand H. Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells on nanofibers and their transplantation into a carbon tetrachloride-induced liver fibrosis model. Stem Cell Rev 2011; 7: 103-118.
Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW, et al. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2007; 2: e941.
Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, Deregibus MC, et al. Isolation and characterization of a stem cell population from adult human liver. Stem Cells 2006; 24: 2840-2850.
Herrera MB, Fonsato V, Gatti S, Deregibus MC, Sordi A, Cantarella D, et al. Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med 2010; 14: 1605-1618.
Kanazawa H, Fujimoto Y, Teratani T, Iwasaki J, Kasahara N, Tsuruyama T, et al. Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model. PLoS One 2011; 296: e19195.
Lehmann V, Freudenberg MA, Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med 1987; 165: 657-663.
Herrera MB, Bussolanti B, Bruno S, Morando L, Mauriello-Romanazzi G, Sanavio F, et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 2007; 72: 430-441.
Boddington SE, Sutton EJ, Henning TD, Nedopil AJ, Sennino B, Kim A, et al. Labeling human mesenchymal stem cells with fluorescent contrast agents: the biological impact. Mol Imaging Biol 2011; 13: 3-9.
Sutton EJ, Boddington SE, Nedopil AJ, Henning TD, Demos SG, Baehner R, et al. An optical imaging method to monitor stem cell migration in a model of immune-mediated arthritis. Opt Express 2009; 17: 24403-24413.
Dhawan A, Puppi J, Hughes RD, Mitry RR. Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol 2010; 7: 288-298.
Cho KA, Lim GW, Joo SY, Woo SY, Seoh JY, Cho SJ, et al. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Liver Int 2011; 31: 932-939.
Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H, et al. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. HEPATOLOGY 2004; 40: 1304-1311.
Zagoura DS, Roubelakis MG, Bitsika V, Trohatou O, Pappa KI, Kapelouzou A, et al. Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure. Gut 2012; 61: 894-906.
Strick-Marchand H, Masse GX, Weiss MC, Di Santo JP. Lymphocytes support oval cell-dependent liver regeneration. J Immunol 2008;18:2764-2771.
Van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. HEPATOLOGY 2008; 47: 1634-1643.
Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H. The role of vascular endothelial growth factor in wound healing. J Surg Res 2009; 153: 347-358.
Tögel F, Zhang P, Hu Z, Westenfelder C. VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. J Cell Mol Med 2009; 13: 2109-2114.
Martin D, Galisteo R, Gutkind JS. CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex. J Biol Chem 2009; 284: 6038-6042.
